Active Ingredient History

NOW
  • Now
Apatinib, also known as Rivoceranib, is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2. It is an orally bioavailable, small molecule agent which is thought to inhibit angiogenesis in cancer cells; specifically apatinib inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue. This agent also mildly inhibits c-Kit and c-SRC tyrosine kinases.   Wikipedia

  • SMILES: O=C(Nc1ccc(cc1)C2(CCCC2)C#N)c3cccnc3NCc4ccncc4
  • InChIKey: WPEWQEMJFLWMLV-UHFFFAOYSA-N
  • Mol. Mass: 397.48
  • ALogP: 4.68
  • ChEMBL Molecules:
More Chemistry
apatinib | apatinib mesylate | yn968d1 | yn-968d1

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue